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Background. Silver nanoparticles have found wider and increasing biomedical applications due to their broad antimicrobial
characteristics. However, toxicity of nanoparticles is a subject of continued controversy, thus necessitating further studies in this
direction. Objectives. This study investigated the biochemical effects of silver nanoparticles in Wistar rats.Materials and Methods.
Forty male rats were randomly distributed into eight experimental groups of five. Group A served as the control and received
distilled water. Groups B to H were orally exposed to varying concentrations of silver nanoparticles (AgNPs) at 100, 1000, and
5000mg/kg daily for 7, 14, and 21 days alternately. Following cessation of treatments, rats were sacrificed and the blood and other
vital organs were collected and prepared as specimens for biochemical analysis. Results. Administration of AgNPs to rats did not
produce significant loss in feed intake and body weight. However, rat exposure to AgNPs caused significant alterations to levels of
serum and tissue AST, ALT, and ALP. At the 100mg/kg AgNPs exposure, rat serum and tissue AST andALT levels were significantly
decreased (P < 0.05). In contrast, AgNPs administration elevated (P < 0.05) ALP levels in rat serum and tissues. Conclusion. We
show evidence that AgNPs administration to Wistar rats altered some biochemical parameters.
1. Introduction
The small sizes of the nanoparticles and large surface to vol-
ume ratio put the nanoparticles in a position for tremendous
and wide applications essentially in biomedicine. Though
the small sizes of engineered nanoparticles have been linked
with highly desirable properties (mechanical, electrical, and
chemical) for specific uses, yet these same desirable proper-
ties are also likely to be associated with unwanted biologi-
cal/toxicological reactivity [1]. This raises risk concern issues
on the use of nanoparticles for biomedical purposes.
Although metal nanoparticles have received increas-
ing attention due to their widespread medical, consumer,
industrial, and military applications, studies have correlated
particle size of some metal-based nanoparticles (e.g., Ag, Au,
and Cu) with toxicity, even if the same material is relatively
inert in its bulk form [2, 3]. Indeed, there are increasing
concerns about the safety of nanoparticles for human health
and environment [4–6], highlighting the need for further
investigations on the safety of metal nanoparticles. Moreover,
data on the safety/toxicity profiles of metal nanoparticles are
scarce.
Perhaps, the fears of health risks may not be completely
unfounded, if the small sizes and the large surface area
to volume ratio as well as the chemical reactivity and/or
biological activity of the nanoparticles are to be considered.
Also there are studies revealing the potential of nanoparticles
to alter normal physiology by interacting with biomolecules
in living cells [7–9] thereby causing adverse effects at the
cellular, subcellular, and protein levels [3].
Furthermore, nanoparticles enter the human body
through ingestion, inhalation, and skin contact or genitou-
rinary tract and become deposited in vital organs such as
brain, liver, or kidneys [10, 11]. Studies have shown that
nanoparticles may change or damage cellular processes
by passing through cellular membranes to interact with
biomolecules leading to DNA and protein damage [12, 13] or
cross the blood-brain barrier to cause neurotoxicity [14].
These factors underscore the urgent need for investiga-
tions aimed at establishing the influence of nanoparticles on
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Figure 1: UV/Vis spectrum at 430 nm maximum (a) and TEM images of silver nanoparticles (b).
biochemical parameters. The present study determined the
effect of the oral administration of silver nanoparticle on
some biochemical parameters in Wistar rats.
2. Materials and Methods
2.1. Reagents. Alanine aminotransferase (ALT), aspartate
aminotransferase (AST), and alkaline phosphatase (ALP)
assay kits were supplied by Randox Laboratory (Crumlin,
UK). All other reagents were of analytical grade and were
prepared in distilled water unless otherwise stated.
2.2. Experimental Animals. Male rats of Wistar strain weigh-
ing between 170 and 180 g were obtained from the University
of Ibadan, Ibadan, Nigeria. Animals were housed in hygienic
environment and allowed to acclimatize for a week before
commencement of treatments. Animals were fed with com-
mercial rat chows and given clean water ad libitum.
2.3. Preparation of Silver Nanoparticles (AgNPs). The prepa-
ration and characterization of silver nanoparticles were as
previously reported [15, 16]. Briefly, the AgNPs were made
by adding 100mM silver nitrate to a 1% (w/v) tannic acid
solution (pH adjusted to 8 by adding 150mM potassium
carbonate) of polyvinylpyrrolidone (PVP) with stirring.
The solution became pale yellow (AgNPs). The AgNPs
were filtered using the 0.22 𝜇M filter and characterized by
UV/Vis spectrophotometry (Biotek Epoch,USA), inductively
coupled plasma optical emission spectrometry (ICP-OES,
Cambridge, United Kingdom), and transmission electron
microscopy (TEM, Brno, Czech Republic).
2.4. Animal Groupings and Treatments. Animals were ran-
domly assigned into eight experimental groups A–H of five
rats per group. Further details of animal distribution are as
given.
GroupA served as control and received distilledwater
daily.
Groups B, C, andD eachwere daily administeredwith
100, 1000, and 5000mg/kg AgNPs, respectively, for 7
days.
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Figure 2: Effects of silver nanoparticles on the weight of the Wistar
rats. Values are expressed as mean ± standard error of mean (SEM,
𝑛 = 5). Values at 𝑃 < 0.05 are significant. ∗ versus control; Φ versus
1000mg 14-day treatment.
Groups E, F, and G each were daily administered with
100, 1000, and 5000mg/kg AgNPs, respectively, for 14
days.
Group H received 5000mg/kg AgNPs daily for 21
days.
The AgNPs were diluted in distilled water. Doses were
fixed based on a recent report which demonstrated that
the LD
50
for silver nanoparticles (AgNPs) was greater than
5000mg/kg [17]. All treatments were orally administered
with the aid of a cannula and animals sacrificed alternately 24
hours after cessation of treatments.The study was carried out
in accordance with institutional guidelines on the handling of
animals as approved for scientific research. The size range of
the AgNPs used was between 8 and 20 nm.
2.5. Necroscopy. 24 hours following cessation of last treat-
ments, rats were sacrificed under anaesthetization in slight
International Scholarly Research Notices 3
0.000 100.000 1000.000 5000.000
0.0
0.1
0.2
0.3
To
ta
l p
ro
te
in
 (g
/d
L)
𝛼
𝛼
𝛼
𝛼
𝛼 𝛼
𝛼
Body weight (mg/kg)
(a)
0.0 100.0 1000.0 5000.0
0.0
0.5
1.0
1.5
To
ta
l p
ro
te
in
 (g
/d
L)
Body weight (mg/kg)
𝛼
𝛼
𝛼
𝛼
𝛼
(b)
0.0 100.0 1000.0 5000.0
0.00
0.25
0.50
0.75
To
ta
l p
ro
te
in
 (g
/d
L)
7 days
14 days
21 days
Body weight (mg/kg)
𝛼
𝛼
𝛼 𝛼
𝛼
(c)
0.00 100.00 1000.00 5000.00
0.0
0.1
0.2
0.3
0.4
To
ta
l p
ro
te
in
 (g
/d
L)
7 days
14 days
21 days
Body weight (mg/kg)
𝛼
𝛼
𝛼
𝛼
𝛼
𝛼
𝛼
(d)
Figure 3: Effects of silver nanoparticles on total protein levels in rat (a) serum, (b) liver, (c) kidney, and (d) heart. Values are expressed as
mean ± standard error of mean (SEM, 𝑛 = 5). Values at 𝑃 < 0.05 are significant. 𝛼 versus the control group.
chloroform. Blood samples were obtained by cardiac punc-
ture into clean centrifuge bottles and spun at 4000×g for 5
minutes (Heraeus Labofuge 300, Thermo Scientific, Hamp-
shire, UK) to yield the serum. The heart, liver, and kidneys
from each animal were excised and weighed immediately.
Excised tissues were homogenized in ice-cold 0.25M sucrose
(1 : 5 w/v) using a Teflon homogeniser (Sigma-Aldrich
Chemie GmbH,Munich, Germany).The tissue homogenates
were centrifuged at 4000×g for 5minutes (Heraeus Labofuge
300,Thermo Scientific, Hampshire, UK) to remove unbroken
particulates. Various biochemical parameters were subse-
quently estimated from the serum and supernatants of tissue
homogenates.
2.6. Biochemical Assays. The following biochemical param-
eters were determined in rat serum, kidney, liver, and heart
using a UV/Vis spectrophotometer (Shimadzu, Kyoto, Japan)
where applicable; protein concentrations in serum and tis-
sue homogenates were estimated as described by Gornall
et al. [18]. Aspartate aminotransferase (AST) was determined
using commercial Randox kit [19, 20]. Alanine aminotrans-
ferase (ALT) was determined using commercial Randox
kit [18]. Alkaline phosphatase (ALP) was determined using
commercial Randox kit [21].
2.7. Data Analysis. All data were presented as the mean ±
SEM. Data were subjected to statistical analysis using one-
way ANOVA with GraphPad Prism 3.0 (GraphPad Software
Inc., San Diego, CA). Post hoc test was performed using the
Dunnett test. Mean values were considered to be statistically
significant at 𝑃 < 0.05.
3. Results
The AgNPs produced had a brownish yellow colour. The
AgNPs had a maximal UV absorption at 430 nm with diam-
eter sizes ranging between 8 and 20 nm (Figure 1). Treatment
with AgNPs at the dose of 5000mg/kg caused dullness in the
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Figure 4: Effects of silver nanoparticles on alkaline phosphatase (ALP) levels in rat (a) serum, (b) liver, and (c) kidney. Values are expressed
as mean ± standard error of mean (SEM, 𝑛 = 5). Values at 𝑃 < 0.05 are significant. 𝛼 versus the control group.
rats, with one death recorded in the same group. No further
symptoms of toxicity were observed. The relative organ-to-
body weight ratios for the animals are presented in Table 1.
There are no significant differences when comparing between
the AgNPs treatment groups and the control. The weights
of the rats treated with silver nanoparticles increased at all
concentrations (Figure 2). However, the weight increments
were only significant in the 1000mg/kg for 14 days as well
as the 5000mg/kg for 21 days. Treatment of rats with AgNPs
caused elevation (𝑃 < 0.05) in total protein levels in rat
liver (Figure 3). In contrast, the levels of total protein were
reduced in rat serum, kidney, and heart for groups treated
with AgNPs.
Oral exposure of rats to AgNPs at various concentrations
inconsistently altered the serum and tissue levels of ALP
relative to the control (Figure 4). In the serum, level of ALP
increasedwith increasing length of treatment administration.
In contrast, nonsignificant reductions were recorded for
tissue levels of ALP caused by AgNPs treatments.
For all the AgNPs treatment groups, the rat serum and
tissue levels of AST were inconsistently affected relative to
the control (Figure 5). Conversely, there was significant (𝑃 <
0.001) reduction in the levels of ALT in rat serum which was
dose and duration dependent (Figure 6). On the other hand,
the rat kidney and heart levels of ALT were not significantly
altered by AgNPs treatment relative to control.
4. Discussion
The literature has shown that AgNPs are widely used due to
their antimicrobial effects. Humans can be exposed to these
nanomaterials via a number of routes with the nanoparticles
tending to accumulate in vital organs [22]. According to Gatti
[23], nanoparticle deposition in vital organs or tissues could
induce cellular damage.
This study evaluated the effects of AgNPs in rats at various
dosages. The AgNPs treatments did not produce significant
loss in feed intake and body weight. Although one death
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Table 1: Effects of silver nanoparticles (AgNPs) on organ to body weight ratio of Wistar rats. Values are expressed as mean ± standard error
of mean (SEM, 𝑛 = 5).
Groups Liver Kidney Heart
Control 0.033 ± 0.0034 0.0056 ± 0.00065 0.0029 ± 0.00008
100mg/kg for 7 days 0.026 ± 0.0054 0.0055 ± 0.00016 0.0029 ± 0.00047
1000mg/kg for 7 days 0.035 ± 0.0033 0.006 ± 0.00039 0.0038 ± 0.00023
5000mg/kg for 7 days 0.032 ± 0.0011 0.0054 ± 0.00014 0.0032 ± 0.00023
100mg/kg for 14 days 0.032 ± 0.0012 0.0050 ± 0.00031 0.0028 ± 0.00016
1000mg/kg for 14 days 0.030 ± 0.0014 0.0057 ± 0.00034 0.0030 ± 0.00019
5000mg/kg for 14 days 0.033 ± 0.0018 0.0053 ± 0.00037 0.0031 ± 0.00024
5000mg/kg for 21 days 0.036 ± 0.0011 0.0059 ± 0.00031 0.0031 ± 0.00008
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Figure 5: Effects of silver nanoparticles on aspartate transaminase (AST) levels in rat (a) serum, (b) liver, (c) kidney, and (d) heart. Values
are expressed as mean ± standard error of mean (SEM, 𝑛 = 5). Values at 𝑃 < 0.05 are significant. 𝛼 versus the control group.
was recorded, no further adverse signs or symptoms were
recorded. The death could have been accidental. However,
treatment at 5000mg/kg AgNPs caused dullness in rats. The
physical observation supports previous report [17] which
reported no death and no effect on the percentage weight
gain between the control and treatment groups of mice orally
given 5,000mg/kg of colloidal AgNPs.
Biochemical indices have significance inmonitoring clin-
ical symptoms produced by a toxicant. Moreover, enzyme
assays play a crucial role in toxicological evaluation [24]. In
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Figure 6: Effects of silver nanoparticles on alanine transaminase (ALT) levels in rat (a) serum, (b) liver, (c) kidney, and (d) heart. Values are
expressed as mean ± standard error of mean (SEM, 𝑛 = 5). Values at 𝑃 < 0.05 are significant. 𝛼 versus the control group.
the past several years, serum aminotransferases analyses have
become a standard measure of hepatotoxicity because of the
significance of these enzymes. Normally, these enzymes are
present in the liver and other tissues where they function in
energy metabolism involving the transamination of amino
acids. However, in cases of cellular damage, the AST and ALT
could leak out into the general circulation leading to elevated
activity [24–26].
In the present study, the treatment of rats with 100mg/kg
AgNPs decreased (𝑃 < 0.001) levels of AST and ALT enzyme
significantly, whereas there were increases (𝑃 < 0.001) in
AST levels in serum, kidney, and heart for the 14- and 21-
day treatment groups. Treatment of rats with 1000mg/kg and
5000mg/kg AgNPs led to a significant decrease in ALT levels
and a significant increase in AST levels for the 14- and 21-
day treatment groups. In contrast, AST levels significantly
decreased while ALT levels increased in rat serum treated
with colloidal AgNPs for 7 days when compared with those
treated for 21 days [17]. This study also caused elevated
(𝑃 < 0.05) levels of rat serum ALP levels. The effect of
the oral administration of AgNPs to rats on ALP, AST, and
ALT did not follow a definite pattern but may suggest partial
inactivation of enzyme activity or depression of enzyme
synthesis. Although the liver has been reported as one of the
recurrent target organs and a dominant site of accumulation
of nanoparticles [27], the alterations to the levels of enzymes
may represent adaptive mechanisms by the animals trying to
offset stress imposed by exposure to the AgNPs. The dosages
at 100mg/kg produced more significant alterations to the
biochemical parameters than did the higher dosages at 1000
and 5000mg/kg, respectively. However, a previous study has
demonstrated that administration of AgNPs to rats caused
significant alterations to the ALP levels [28]. Furthermore,
alterations to the levels of AST, ALT, or ALP may not be
unconnected with the affinity of AgNPs for thiol groups
in protein molecules [29]. Moreover, a separate study by
Srivastava et al. [30] has also demonstrated the potential
of AgNPs to affect the activity of transaminase enzymes.
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In separate studies, the potential of silver nanoparticles to
modulate enzyme activity was attributable to their affinity
for thiol groups [15, 16]. It is probable that thiol groups in
the enzymes made them attractive to the AgNPs leading
to formation of complexes and consequent modulation of
enzyme activity. Furthermore, the pronounced biochemical
alterations noticed with the 100mg/kg AgNPs in the present
study may not be completely consistent with earlier report
[17] in which AgNPs had an LD
50
of >5000mg/kg in mice.
5. Conclusion
The administration of AgNPs in rats did not induce major
changes in body weight and feed intake. However, this study
is evidence indicating that rat tissue biochemical indices were
altered following oral exposure to AgNPs. Future studies
are ongoing and target the determination of whether the
alterations to the biochemical parameters were signs of
AgNPs toxicity or not.
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